Cilostazol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01166 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 17 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | intracranial arteriosclerosis | KG + DL |
| 2 | Monckeberg arteriosclerosis | KG + DL |
| 3 | peripheral vascular disease | KG + DL |
| 4 | kyphoscoliotic heart disease | KG + DL |
| 5 | uterine polyp | KG + DL |
| 6 | polyp of vocal cord | KG + DL |
| 7 | polyp of middle ear | KG + DL |
| 8 | epulis | KG + DL |
| 9 | polyp of frontal sinus | KG + DL |
| 10 | polyp of ureter | KG + DL |
| 11 | peripheral arterial disease | KG + DL |
| 12 | fibroepithelial polyp | KG + DL |
| 13 | polyp of external auditory canal | KG + DL |
| 14 | polyp of vulva | KG + DL |
| 15 | neoplastic polyp | KG + DL |
| 16 | priapism | KG + DL |
| 17 | pulmonary hypertension | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.